Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density

BACKGROUND AND OBJECTIVE: Abaloparatide, an anabolic osteoporosis treatment administered by subcutaneous (SC) injection, increases bone mineral density (BMD) and reduces fracture risk in postmenopausal women with osteoporosis. The abaloparatide-solid Microstructured Transdermal System [abaloparatide...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Drug Investig
Main Authors: Miller, Paul D., Troy, Steven, Weiss, Richard J., Annett, Miriam, Schense, Jason, Williams, Setareh A., Mitlak, Bruce
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2021
Assuntos:
Original Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7946681/
https://ncbi.nlm.nih.gov/pubmed/33638863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-021-01008-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares